Testing for high-risk types of alpha human papillomaviruses (HPV) is an invaluable part of
clinical guidelines for cervical carcinoma screening, management and treatment. In this …

Commercial molecular tests for human papillomaviruses (HPV) are invaluable diagnostic
tools in cervical carcinoma screening and management of women with cervical …

Human papillomavirus (HPV) infection is associated with a wide spectrum of disease that
ranges from self-limited skin warts to life-threatening cancers. Since HPV plays a necessary …

Background Although cervical screening using Human Papillomavirus (HPV) testing is
globally recommended public health policy, there has been no international proficiency …

Cervical cancer screening incorporating high-risk human papillomavirus (HPV) detection
has become the preferred screening strategy in some countries and is increasingly more …

Human papillomavirus (HPV) is a well-studied etiologic agent for cervical cancer dysplasia
and neoplasia. HPV E6 and E7 viral proteins drive oncogenesis by blocking the activity of …

Humam papillomavirus is the commonest genital viral infection in healthy sexually active
subjects, and the presence of chronic or persistent HPV types in genital cells may constitute …

Background Molecular tests for detection of human papillomaviruses (HPVs) play a crucial
role in the prevention of cervical cancer, including recently announced elimination efforts …

BACKGROUND: Testing for human papillomavirus (HPV) has emerged as an important
component of cervical cancer screening and disease management. Analytic performance …

High-risk human papillomaviruses (HPVs) cause essentially all cervical cancers, most anal
and oropharyngeal cancers, and some vaginal, vulvar, and penile cancers. Improved …